TRANSMEDICA A/S: Financial statements 2022
CVR: 17423401
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
TRANSMEDICA A/S (CVR 17423401) has filed annual accounts for 2022. In 2022, the company reported revenue of DKK 273,523,000 and a net result of DKK 13,711,000 compared with DKK 2,401,000 the year before. That is an increase of 14.7% compared with the year before. The profit margin was 5%. Equity in the 2022 report amounted to DKK 41,497,000. The solvency ratio was 62.7%. The company had 101 employees in the financial year.
- Revenue
- DKK 273,523,000
- Gross Profit
- DKK 182,817,000
- Profit/Loss
- DKK 13,711,000
- Equity
- DKK 41,497,000
- Total Assets
- DKK 66,152,000
- Employees
- 101
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | 273.5M | 182.8M | 13.7M | 41.5M | 101 |
| 2021 | 238.5M | 168.3M | 2.4M | 27.9M | 134 |
| 2020 | 193M | 138.4M | 4.4M | 35.5M | 118 |
| 2019 | 184.5M | 139.5M | 5.6M | 31.1M | 109 |
| 2018 | 143.8M | 99.7M | -3M | 25.5M | - |
Official annual report
Keep an eye on TRANSMEDICA A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
TRANSMEDICA A/S has published its annual report for 2021. Revenue came to DKK 238,479,000, and the net result was DKK 2,401,000.
About TRANSMEDICA A/S
TRANSMEDICA A/S is a Danish company of the type Aktieselskab based in København V, founded in 1993. The company is registered under the industry Vikarbureauers aktiviteter og anden personaleformidling. The company was previously named TRANSMEDICA ApS and GLOBAL MEDICAL SERVICE ApS. The management consists of Mikael Palm and Pia Cens. The board consists of Stig Løkke Pedersen (chair), Bo Prangsgaard and Mikael Palm. The company is owned by EVASIJU HOLDING ApS and Transmedica-Nordvik Holding ApS. The company has 56 employees (2026). In 2025, the company reported revenue of DKK 157,997,000 and a net result of DKK -18,330,000 compared with DKK -269,000 the year before. Equity in the 2025 report amounted to DKK 20,507,000.